These were novel findings that show how insulin and IGF1 downstream signaling cascades differ in cancer cells; however, the mechanisms for these differences were obfuscated by the distance of E-cadherin and ACC from the InsR and IGF1R signaling pathways. This evidence concerns the gene IGF1R and cancer.